Home > Press > Mass-Producing Tunable Magnetic Nanoparticles
Abstract:
Taking a cue from the semiconductor industry, a team of investigators at Stanford University has developed a method of producing unlimited quantities of highly magnetic nanoparticles suitable for use as magnetic resonance tumor imaging agents. Equally important, this method can be easily tailored to produce nanoparticles with a wide range of well-defined magnetic properties. Tunability creates the opportunity to use these nanoparticles in multiplexed biosensing applications akin to those now being developed using tunable quantum dots of multiple colors.
Shan Wang, Ph.D., a member of the Center for Cancer Nanotechnology Excellence Focused on Therapy Response, one of eight Centers of Cancer Nanotechnology Excellence (CCNEs) funded by the NCI, led a research team that has been exploring methods of creating large, uniform batches of magnetic nanoparticles. Their current work, reported in the journal Advanced Materials, describes a technique for fabricating magnetic nanoparticles that involves forming two magnetic layers sandwiched around a layer of nonmagnetic material.
To create these sandwich particles, the investigators use a technique known as nanoimprint lithography to create cobalt-iron nanodisks. As a nonmagnetic spacer, the researchers used nanometer-thick layers of ruthenium. By varying the thickness of the ruthenium spacer layer, the investigators found they could alter the magnetic properties of the resulting nanodisks in a predictable manner. The disks are coated with a thin layer of tantalum to stabilize them.
In addition to producing nanoparticles with tunable magnetic properties, the researchers showed that they could use nanoimprint lithography to add additional layers of materials that afforded the resulting disks with other useful properties. For example, the investigators added a layer of gold onto the tantalum surfaces, creating magnetic nanoparticles that could also be detected using surface plasmon resonance imaging, a sensitive optical imaging technique.
This work, which was supported by the NCI's Alliance for Nanotechnology in Cancer, is detailed in the paper "High-Moment Antiferromagnetic Nanoparticles with Tunable Magnetic Properties." There is no abstract available for this paper, but a citation is available at the journal's Web site.
####
About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580
Copyright © National Cancer Institute
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Related News Press |
Imaging
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||